Dojindo Molecular Technologies, Inc Company Profile

19:06 EDT 18th September 2018 | BioPortfolio

Dojindo's Company history dates back to the establishment of the Dojindo Pharmacy in 1910's by Keiji Ueno. Since then, Dojindo has been making products to back up the progress of scientific research. Today, Dojindo produces over 800 well-known products used by research organizations in many disciplines. Many of these products were developed jointly between Dojindo staff and outside researchers. Dojindo strives to expand its ability to analyze the future direction of science by maintaining continued interest in new research activities as well as improving its information-gathering network. As we move toward the 21st century, Dojindo expects that the time to produce a new product will be shortened. Dojindo is ready for this shortened product cycle because our creative researchers are working ceaselessly to meet tomorrow's research needs.


211 Perry Parkway, Suite 5
United States of America


Phone: (301) 987-2667
Fax: (301) 987-2687

News Articles [679 Associated News Articles listed on BioPortfolio]

Australian molecular Dx company looks to expand into China

Genetic Technologies, an Australian molecular diagnostics company, has entered a partnership with Beijing Zishan Health Consu -More- 

#jobs #lifescience Wellcome Trust Sanger Institute: Advanced Research Assistant – Mouse Molecular Technologies

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Wellcome Trust Sanger Institute: Advanced Research Assistant – Mouse Mo...

Akonni, Righton swap MDx products and technologies

Fellow molecular diagnostics players Akonni Biosystems Inc. and Righton teamed up in a commercialization partnership that has the companies licensing one another's products and technologies.

AquaBounty on the verge of a major growth spurt as they transition from R&D to operations

Ronald Stotish, president and chief executive of AquaBounty Technologies (NASDAQ:AQB), tells Proactive they're a small biotechnology company that was founded roughly 20 years ago with the strategic ...

The Molecular Autopsy: Not Ready Yet for Prime Time

Although I have always been a strong advocate for sophisticated molecular and genomic testing, I tend to get a severe case of indigestion when I see references to the molecular autopsy (see: Can Inter...

Molecular Health introduces MH Mendel to help geneticists in diagnosing hereditary diseases

Molecular Health, a leading biomedical company that is transforming molecular data into clinically actionable information for efficient and safer cancer treatment options based on its proprietary Data...

One Type Of Data Is Not Enough In Personalized Medicine

ArticleThe big challenge in cancer is that each patient's disease is different from a molecular point of view and has a unique set of molecular features that have led to its development, according to ...

Molecular switches are not just 'on' or 'off'

(Aarhus University) It is not always easy to see if a switch is on or off! A new study shows that the same can be true of a molecular switch. This knowledge gives a new insight into the molecular swit...

PubMed Articles [1091 Associated PubMed Articles listed on BioPortfolio]

Long Reads: their Purpose and Place.

In recent years long read technologies have moved from being a niche and specialist field to a point of relative maturity likely to feature frequently in the genomic landscape. Analogous to next gener...

Progressive Approach for SNP Calling and Haplotype Assembly Using Single Molecular Sequencing Data.

Haplotype information is essential to the complete description and interpretation of genomes, genetic diversity and genetic ancestry. The new technologies can provide Single Molecular Sequencing (SMS)...

Adoption of Stroke Rehabilitation Technologies by the User Community: Qualitative Study.

Using technology in stroke rehabilitation is attractive. Devices such as robots or smartphones can help deliver evidence-based levels of practice intensity and automated feedback without additional la...

Sepsis Diagnostics in the Era of "Omics" Technologies.

Sepsis is a multifactorial clinical syndrome with an extremely dynamic clinical course and with high diverse clinical phenotype. Early diagnosis is crucial for the final clinical outcome. Previous stu...

Nucleic acid-barcoding technologies: converting DNA sequencing into a broad-spectrum molecular counter.

The emergence of high-throughput DNA sequencing technologies sparked an immediate revolution in the field of genomics that has rippled into many branches of the life and physical sciences. The remarka...

Clinical Trials [1720 Associated Clinical Trials listed on BioPortfolio]


Most neurological and neurodegenerative diseases have a multifactorial nature. For some of them it is documented a genetic component (sometimes described as Mendelian, other times as a mul...

Establishment of Comprehensive Genetic Analysis From a Single Cell

Preimplantation genetic diagnosis (PGD) is the integration of both assisted reproductive technologies and molecular genetic technologies and was shown to improve implantation rate and redu...

Tissue Collection Framework To Improve Outcomes In Solid Tumours

Background: Cancer therapies have significantly improved over the last decades, allowing cancer specialists to keep cancer under control for longer than ever before. However, metastatic ...

Lung Allograft Rejection Gene Expression Observational (LARGO) Study

The objective of the LARGO Study protocol is to collect peripheral blood samples, select associated lung biopsy pathology slides, and clinical data from lung transplant recipients to perfo...

NGS Strategy Effectiveness in Molecular Diagnosis

The coming out of Next Generation Sequencing (NGS) technologies, with documented advantages and reduced costs respect to Sanger sequencing, has provided new appealing approaches to diagnos...

Companies [2117 Associated Companies listed on BioPortfolio]

Dojindo Molecular Technologies, Inc

Dojindo's Company history dates back to the establishment of the Dojindo Pharmacy in 1910's by Keiji Ueno. Since then, Dojindo has been making products to back up the progress of scientific research. ...

Dojindo Laboratories


Seegene Technologies, Inc.

Seegene is the world’s leading developer of multiplex molecular technologies and multiplex clinical molecular diagnostics (M-MoDx). Seegene’s core enabling technologies ...

Seegene Inc.

Seegene is the world’s leading developer of multiplex molecular technologies and multiplex clinical molecular diagnostics (M-MoDx). Seegene’s core enabling technologies ...

Molecular Medicine BioServices (

Molecular Medicine BioServices (MMB) is dedicated to providing a variety of development, manufacturing, and ancillary services for the viral vaccine and viral therapeutic marketplace. In this exciting...

More Information about "Dojindo Molecular Technologies, Inc" on BioPortfolio

We have published hundreds of Dojindo Molecular Technologies, Inc news stories on BioPortfolio along with dozens of Dojindo Molecular Technologies, Inc Clinical Trials and PubMed Articles about Dojindo Molecular Technologies, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dojindo Molecular Technologies, Inc Companies in our database. You can also find out about relevant Dojindo Molecular Technologies, Inc Drugs and Medications on this site too.

Quick Search


Relevant Topic

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Corporate Database Quicklinks

Searches Linking to this Company Record